Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxaliplatin with 5FU and Folinic Acid in Advanced Gastric Cancer
NCT00611507Phase 2Completed
- Sponsor
- Sanofi
- Start
- Nov 2002
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in gastric cancer (GC), sponsored by Sanofi. Started Nov 2002; status: completed.
02
Drugs
oxaliplatin
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT00611507.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00611507.